CORE L: Clinical Research Facilitation Core. The UCLA CFAR Clinical Research Facilitation Core (Core L) provides support for investigators and their staff who are engaged in research involving human subjects with an overall goal to reduce the time between project funding and the initiation and completion of the research. The core has 2 specific aims: 1) To assist investigators with the regulatory approval aspects of biomedical, behavioral and basic translational patient-oriented research in HIV;2) To establish and maintain a continually-updated research participants'registry that will assist investigators with identifying and enrolling subjects into patient-oriented HIV research at UCLA. This core has created a streamlined process for IRB and other regulatory filing and established a v/ay to identify and contact potential research subjects, which reduces costs and the time needed to receive various institutional regulatory approvals and to identify potential subjects for their research. In addition new clinical and translational faculty as well as fellows and postdoctoral students receive training from this core in human subjects regulatory requirements, in proper IRB and other required submissions and how best to recruit for subjects from the diverse and often hard-to-reach populations of HIV-infected and at-risk individuals in the greater LA community. The core provides UCLA investigators, research trainees and staff access to resources that would otherwise not be available or which may be unaffordable to help expedite their research. The UCLA CFAR Clinical Research Facilitation Core also provides valuable recruitment and enrollment tools which help both existing and new faculty expedite their research and which serves as an attractive value added resource for the recruitment and retention of faculty working in HIV at UCLA. To accomplish these aims the Clinical Research Facilitation Core maintains a Regulatory Support arm, and within the last year, has designed and initiated the Research Study Volunteer Project (RSVP) arm, each of which provides services to UCLA CFAR investigators and trainees involved in HIV research who choose to avail themselves of these services. The RSVP program, initiated in late 2011, is in its subject recruitment and implementation phase. We intend to expand and make it more widely available with this competitive renewal.

Public Health Relevance

The CORE L Regulatory Support provides a centralized resource for assisting investigators in meeting the complex regulatory requirements for conducting patient-oriented research. The Research Study Volunteer Project (RSVP) serves as a resource for CFAR investigators to improve the efficiency of their research efforts by creating and maintaining a database of HIV-infected and uninfected individuals in the Los Angeles area who are interested and willing to be contacted for HIV-related research studies and/or are willing to have their self-reported medical information mined for research

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028697-25
Application #
8631029
Study Section
Special Emphasis Panel (ZAI1-UKS-A)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
25
Fiscal Year
2014
Total Cost
$348,728
Indirect Cost
$68,644
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Fulcher, Jennifer A; Shoptaw, Steven; Makgoeng, Solomon B et al. (2018) Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus. J Acquir Immune Defic Syndr 78:119-123
Walser, Tonya C; Jing, Zhe; Tran, Linh M et al. (2018) Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78:1986-1999
Kojima, Noah; Klausner, Jeffrey D (2018) Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection. AIDS 32:272-275
Chua, Bernadette Anne; Ngo, Jamie Ann; Situ, Kathy et al. (2018) Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515:176-190
Allyn, P R; O'Malley, S M; Ferguson, J et al. (2018) Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection. Int J STD AIDS 29:334-340
Khamaikawin, Wannisa; Shimizu, Saki; Kamata, Masakazu et al. (2018) Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 9:23-32
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3:
Gorbach, Pamina M; Javanbakht, Marjan; Bolan, Robert K (2018) Behavior change following HIV diagnosis: findings from a Cohort of Los Angeles MSM. AIDS Care 30:300-304
Rotheram-Borus, Mary Jane; Davis, Emily; Rezai, Roxana (2018) Stopping the rise of HIV among adolescents globally. Curr Opin Pediatr 30:131-136
Allan-Blitz, Lao-Tzu; Sakona, Ashyln; Wallace, William D et al. (2018) Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017. Emerg Infect Dis 24:

Showing the most recent 10 out of 942 publications